29 results
S-3ASR
EX-1.2
ZNTL
Zentalis Pharmaceuticals Inc
29 Feb 24
Automatic shelf registration
5:14pm
in the Registration Statement and Prospectus satisfies the independence standards established by Nasdaq and, with respect to members of the Company’s audit … committee, the enhanced independence standards contained in Rule 10A-3(b)(1) promulgated by the Commission under the Exchange Act.
(aaa) Neither
8-K
EX-3.1
ZNTL
Zentalis Pharmaceuticals Inc
15 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:12pm
of record therefor) with respect to the background, qualifications, stock ownership and independence of such proposed nominee and (ii) a written
DEFA14A
ZNTL
Zentalis Pharmaceuticals Inc
10 May 23
Additional proxy soliciting materials
7:08am
as an independent director under Nasdaq’s heightened independence standards for members of a compensation committee and as a “non-employee director” as defined
PRE 14A
6g9qui44fnnf
18 Apr 23
Preliminary proxy
4:30pm
S-3ASR
EX-1.2
vzc84rub
4 May 21
Automatic shelf registration
5:29pm
S-3
EX-1.2
gpbv5laodv ez
4 May 21
Shelf registration
12:00am
DEF 14A
s5vyi 0l2rc6
23 Apr 21
Definitive proxy
4:05pm
10-K
ahr1u
25 Mar 21
Annual report
7:17am
8-K
EX-3.1
pukv8wkp
19 Mar 21
Amendments to Articles of Incorporation or Bylaws
4:08pm
8-K
EX-10.1
avrcoandee7
2 Oct 20
Entry into a Material Definitive Agreement
4:51pm
424B4
r4nv2ii3pmaoc5cq
31 Jul 20
Prospectus supplement with pricing info
12:00am
DRS
EX-4.1
e4q694e0ng41f5ozqq
10 Jul 20
Draft registration statement
12:00am